M.D. Sass Appoints New Vice President to Equity Team

NEW YORK, Aug. 4 /PRNewswire/ -- M.D. Sass, a leader in investment management for thirty-eight years, is pleased to announce the appointment of Jason Rapp as Vice President and Senior Analyst on its equity team, which manages the firm's flagship Relative Value Equity Strategy and Maximus long/short equity hedge fund.

(Logo: http://photos.prnewswire.com/prnh/20100525/NY09954LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100525/NY09954LOGO)

Mr. Rapp has a deep background as a Senior Analyst for value-oriented long equities and long/short equity funds. He also has experience in mergers and acquisitions, financial restructurings and private equity.

"At M.D. Sass, our equity team is tasked with identifying mispriced equities where market perceptions lag reality and attractive opportunities that others fail to discern. We strive for investments with hidden strengths and take advantage of market inefficiencies," said Martin D. Sass, CEO of M.D. Sass. "Jason's experience in sourcing and analyzing a variety of equity investments reinforces our commitment to rigorous forensic research on compelling equities outside the bounds of conventional wisdom."

Previously, Mr. Rapp was a Senior Analyst at OSS Capital Management LP for its long/short hedge fund. There, he was a generalist responsible for more than $500 million in long and short equity investments at peak, with portfolio management responsibility and trading authorization. Mr. Rapp was also a Senior Analyst at Pierce Street Capital Management LLC for its long/short hedge fund. Earlier, he held positions in the mergers and acquisitions, financial restructurings and private equity spaces.

Mr. Rapp holds an MBA from Harvard University and B.A. in Economics and Political Science from the University of Chicago, and attended the London School of Economics.

About M.D. SASS

M.D. Sass has been a leader in investment management for thirty-eight years. The firm's clients include some of the world's largest corporations, financial institutions, state and local governments, endowment funds, foundations, Taft Hartley funds, fund of funds, and high net worth individuals. Using a proven investment philosophy and rigorous research, M.D. Sass tailors a broad spectrum of investment strategies for clients across equities, fixed income and alternative investments. M.D. Sass's mission is "to be the best investment management firm through superior risk-adjusted returns with the highest degree of client service and ethical standards."

SOURCE M.D. Sass